USDA, FDA to Hold Joint Public Meeting on the Use of Cell Culture Technology.
The Food Safety and Inspection Service (FSIS) and the Food and Drug Administration (FDA) will host a joint public meeting October 23-24, 2018, to discuss the use of cell culture technology to develop products derived from livestock and poultry as announced in a USDA press release. The first day of the meeting will focus primarily on the potential hazards associated with the production of animal cell cultured food products and oversight considerations by regulatory agencies. The second day will address labeling considerations. Interested attendees are encouraged to pre-register here. Written comments may be submitted through November 26, 2018 here. Note that comments must include the Agency name (in this case FDA and FSIS) and docket number FSIS-2018-0036. Comments previously submitted to FDA regarding the July 12, 2018, public meeting will also be considered.
On August 23, 2018, the North American Meat Institute and Memphis Meats co-signed a letter to President Trump in which they asked the Administration to clarify the regulatory framework for cell-based meat and poultry products.
In the letter, Meat Institute President and CEO Barry Carpenter and Memphis Meats Co-founder and CEO Uma Valeti, MD, FACC, said that FDA should have oversight of pre-market safety evaluations for cell-based meat and poultry products. Once safety is established, they said USDA should regulate cell-based meat and poultry products, as it does with all other meat and poultry products.
“Such a regulatory framework is not new and plays into the strengths and experience of FDA and USDA,” Carpenter and Valeti wrote. “We respectfully request a combined meeting between the White House, USDA, FDA and both conventional and cell-based meat and poultry industry stakeholders.”